The Korean Journal of Internal Medicine

Search

Close

Corrigendum Review of Antibody-Drug Conjugates
Han Jo Kim
Korean J Med. 2024;99(5):268-268.
What's new? Review of Antibody-Drug Conjugates
Han Jo Kim
Korean J Med. 2023;98(3):108-116.
Original Articles Clinical outcomes of erlotinib, gefitinib, or pemetrexed in patients with non-squamous, non-small-cell lung cancer
La Young Yoon, Mi Yean Yang, Jina Yun, Hyun Jung Kim, Han Jo Kim, Kyung Ha Kim, Se Hyung Kim, Sang-Cheol Lee, Chan Kyu Kim, Nam Su Lee, Sung Kyu Park, Kyu Taek Lee, Jong-Ho Won, Hee Sook Park, Dae Sik Hong
Korean J Med. 2010;79(4):394-403.
hanmi ckdpharm. AMGEN
Memo patch yungjin daewoongbio

Go to Top